Table 3.
Crude incidence rates (per 100,000 person-years), direct standardized incidence rates (per 100,000 person-years), and standardized rate ratios for each glomerular disease as a function of socioeconomic position
| Income Quintile | N (%) | Crude Rate (95% CI) | Standardized Rate (95% CI) | Standardized Rate Ratio (95% CI) |
|---|---|---|---|---|
| Membranous nephropathy | ||||
| 1 (lowest) | 86 (22) | 0.97 (0.76 to 1.17) | 0.98 (0.77 to 1.19) | 1.11 (0.81 to 1.52) |
| 2 | 89 (23) | 1.02 (0.81 to 1.23) | 1.03 (0.82 to 1.24) | 1.17 (0.86 to 1.59) |
| 3 | 70 (18) | 0.80 (0.61 to 0.98) | 0.81 (0.62 to 1.00) | 0.92 (0.67 to 1.28) |
| 4 | 72 (18) | 0.83 (0.64 to 1.03) | 0.85 (0.65 to 1.04) | 0.96 (0.69 to 1.33) |
| 5 (highest) | 75 (19) | 0.89 (0.69 to 1.10) | 0.88 (0.68 to 1.08) | 1.0 (Reference) |
| ANCA-related GN | ||||
| 1 (lowest) | 96 (25) | 1.08 (0.86 to 1.30) | 1.06 (0.85 to 1.27) | 1.50 (1.09 to 2.06)a |
| 2 | 80 (21) | 0.91 (0.71 to 1.11) | 0.91 (0.71 to 1.10) | 1.28 (0.92 to 1.79) |
| 3 | 84 (22) | 0.95 (0.75 to 1.16) | 0.98 (0.77 to 1.19) | 1.39 (1.0 to 1.94)b |
| 4 | 68 (18) | 0.79 (0.60 to 0.98) | 0.83 (0.64 to 1.03) | 1.18 (0.83 to 1.67) |
| 5 (highest) | 59 (15) | 0.70 (0.52 to 0.88) | 0.71 (0.53 to 0.89) | 1.0 (Reference) |
| IgA nephropathy | ||||
| 1 (lowest) | 190 (23) | 2.14 (1.83 to 2.44) | 2.12 (1.82 to 2.43) | 1.22 (0.98 to 1.51) |
| 2 | 187 (23) | 2.14 (1.83 to 2.44) | 2.12 (1.82 to 2.42) | 1.22 (0.98 to 1.51) |
| 3 | 166 (20) | 1.89 (1.60 to 2.17) | 1.87 (1.59 to 2.16) | 1.08 (0.86 to 1.34) |
| 4 | 130 (16) | 1.51 (1.25 to 1.76) | 1.50 (1.24 to 1.76) | 0.86 (0.68 to 1.09) |
| 5 (highest) | 145 (18) | 1.73 (1.45 to 2.01) | 1.74 (1.46 to 2.03) | 1.0 (Reference) |
| FSGS | ||||
| 1 (lowest) | 100 (27) | 1.13 (0.91 to 1.35) | 1.12 (0.90 to 1.33) | 1.55 (1.13 to 2.13)b |
| 2 | 78 (21) | 0.89 (0.69 to 1.09) | 0.89 (0.70 to 1.09) | 1.24 (0.89 to 1.74) |
| 3 | 64 (17) | 0.73 (0.55 to 0.91) | 0.74 (0.56 to 0.91) | 1.02 (0.72 to 1.46) |
| 4 | 73 (19) | 0.85 (0.65 to 1.04) | 0.87 (0.67 to 1.06) | 1.20 (0.86 to 1.70) |
| 5 (highest) | 60 (16) | 0.71 (0.53 to 0.90) | 0.72 (0.54 to 0.90) | 1.0 (Reference) |
| Lupus nephritis in women | ||||
| 1 (lowest) | 83 (26) | 1.82 (1.43 to 2.22) | 1.81 (1.42 to 2.19) | 1.70 (1.19 to 2.42)c |
| 2 | 75 (23) | 1.68 (1.30 to 2.06) | 1.66 (1.29 to 2.04) | 1.56 (1.08 to 2.26)a |
| 3 | 66 (20) | 1.47 (1.12 to 1.83) | 1.44 (1.10 to 1.79) | 1.36 (0.93 to 1.98) |
| 4 | 54 (17) | 1.24 (0.91 to 1.57) | 1.23 (0.90 to 1.56) | 1.15 (0.78 to 1.72) |
| 5 (highest) | 44 (14) | 1.04 (0.73 to 1.34) | 1.06 (0.75 to 1.38) | 1.0 (Reference) |
| Lupus nephritis in men | ||||
| 1 (lowest) | 17 (25) | 0.39 (0.21 to 0.58) | 0.40 (0.21 to 0.58) | 1.64 (0.76 to 3.55) |
| 2 | 15 (22) | 0.35 (0.17 to 0.53) | 0.35 (0.17 to 0.53) | 1.45 (0.66 to 3.21) |
| 3 | 13 (19) | 0.30 (0.14 to 0.46) | 0.30 (0.14 to 0.46) | 1.24 (0.55 to 2.83) |
| 4 | 12 (18) | 0.28 (0.12 to 0.44) | 0.28 (0.12 to 0.44) | 1.16 (0.50 to 2.69) |
| 5 (highest) | 10 (15) | 0.24 (0.09 to 0.39) | 0.24 (0.09 to 0.39) | 1.0 (Reference) |
P<0.01.
P<0.05.
P<0.001.